Apatinib in HSA-PEG inhibits VEGF-induced retinal vascular permeability and angiogenesis

Subtitle
Apatinib in HSA-PEG inhibits VEGF-induced retinal vascular permeability and angiogenesis
Author(s)
KHANH, NGUYEN HON
Advisor
Sang Gyu Park
Department
일반대학원 약학
Publisher
The Graduate School, Ajou University
Publication Year
2015-08
Language
eng
Keyword
angiogenesispermeabilityVEGFdiabetic retinopathy
Alternative Abstract
Objective: The vascular endothelial growth factor (VEGF) family plays a pivotal role in controlling pathologic vascular angiogenesis and permeability in important eye diseases such as diabetic retinopathy (DR) and age-related macular degeneration (AMD). Developing new therapy in addition to the conventional treatment such as laser photocoagulation to suppress VEGF-induced excessive retinal vascular permeability has emerged as a major research focus. Methods and Results: In this study, we investigated the effect of HSA-PEG/Apatinib-a specific inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2) using a murine model and human retinal microvascular endothelial cell line (HRMEC). Apatinib was efficiently loaded in HSA-PEG, a type of self-assembled nanostructures, which comprises of human serum albumin (HSA) and (poly)ethyleneglycol (PEG) to increase the solubility of water-insoluble drug, thus enhancing pharmacokinetics and bioavailability. To evaluate whether HSA-PEG/Apatinib could inhibit the VEGF-induced angiogenesis, the endothelial proliferation, tube formation and wounding migration were conducted. To assess vascular permeability, in vitro transendothelial resistance and paracellular permeability to dextran and in vivo leakage of intravenous FITC-labeled albumin and Evans blue dye into the retina were measured. Herein, we demonstrated that HSA-PEG/Apatinib significantly inhibited VEGF-induced angiogenesis and hyperpermeability in human retinal microvascular endothelial cells in vitro. In vivo, HSA-PEG/Apatinib significantly inhibited VEGF-mediated vascular leakage and diabetes-induced vascular breakdown in the retinal vessels. Conclusion: Taken together, our findings showed that HSA-PEG/Apatinib could be a potential therapeutic treatment of VEGF-mediated retinal vascular angiogenesis and hyperpermeability in variable ocular diseases.
URI
https://dspace.ajou.ac.kr/handle/2018.oak/13154
Fulltext

Appears in Collections:
Graduate School of Ajou University > Department of Pharmacy > 3. Theses(Master)
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse